Abstract LB-23: Ras Signaling Interrupts TGF-beta-induced KLF5 Acetylation to Alter the KLF5-Smads Transcriptional Assembly in Epithelial Cells

Peng Guo,Changsheng Xing,Xue-Yuan Dong,Jin-Tang Dong

DOI: https://doi.org/10.1158/1538-7445.am2012-lb-23

IF: 11.2

2012-01-01

Cancer Research

Abstract:Abstract β (TGF-β) suppresses early stage tumorigenesis but promotes late stage tumor progression. While also presenting dual roles in tumorigenesis, KLF5 in the acetylated form is essential for TGF-β to properly regulate gene transcription in the inhibition of cell proliferation. The Ras oncogenic signaling not only converts TGF-β from a tumor suppressor to a tumor promoter but also uses KLF5 as a functional effector. One intriguing question is whether and how Ras signaling uses the KLF5 transcription factor to modulate TGF-β function. In this study, we addressed this question by examining whether and how Ras signaling alters TGF-β-induced KLF5 acetylation and the assembly of the p300-KLF5-Smads transcriptional complex in gene regulation. We found that Ras inhibited TGF-β-induced KLF5 acetylation and interfered with TGF-β in p15 induction and Myc repression. In addition, TGF-β-induced Smad3 phosphorylation at the C-terminal region was necessary for TGF-β to induce KLF5 acetylation, and Ras interrupted this phosphorylation. Ras signaling further interrupted the interactions among p300, KLF5 and Smad4, as well as the binding of the p300-KLF5-Smads complex onto the TGF-β-responsive promoter elements for both p15 and Myc. Without TGF-β, however, Ras signaling increased KLF5 acetylation, enhanced the p300-KLF5 interaction, and promoted the binding of the KLF5 transcriptional complex onto the TGF-β-responsive promoter elements. These findings suggest that KLF5 mediates the crosstalk between TGF-β and Ras signaling, and that suppression of TGF-β-induced KLF5 acetylation by Ras signaling alters TGF-β-induced assembly of p300-KLF5-Smads complex onto gene promoters, thus switching the function of TGF-β in gene regulation. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-23. doi:1538-7445.AM2012-LB-23